A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
10/2006
10/12/2006	US20060228363 Monoclonal antibody therapy for pancreas cancer
10/12/2006	US20060228344 Cell-containing preparations
10/12/2006	US20060228342 Method for generating antigen-presenting cells
10/12/2006	US20060228326 Active specific immunotherapy of cancer metastasis
10/12/2006	US20060228297 Thorium-227 for use in radiotherapy of soft tissue disease
10/12/2006	DE102005015240A1 Oral use of ginger to reduce proliferation growth, particularly cancer proliferation in animal and human body
10/12/2006	CA2604133A1 Compounds useful as modulators of the proteasome activity
10/12/2006	CA2604021A1 Piperidyl-2, 6-dione derivatives used to inhibit cells from releasing tumor necrosis factor
10/12/2006	CA2603826A1 Substituted oxazole derivatives and their use as tyrosine kinase inhibitors
10/12/2006	CA2603480A1 Use of an antibody against the laminin receptor or laminin receptor precursor for the treatment or diagnosis of several cancer types
10/12/2006	CA2603478A1 Indazole squaric acid derivatives as chk1-, chk2- and sgk- inhibitors
10/12/2006	CA2603472A1 Pyrazole derivatives
10/12/2006	CA2603398A1 Sulfonylpyrroles as histone deacetylase inhibitors
10/12/2006	CA2603347A1 Oil-in-water emulsions of lignans that exhibit improved absorption rate
10/12/2006	CA2602757A1 Substituted 1,5-naphthyridine azolidinones as cdk inhibitors
10/12/2006	CA2602590A1 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
10/12/2006	CA2602532A1 Pyrrolo [2,3-d] imidazoles for the treatment of hyperproliferative disorders
10/12/2006	CA2602467A1 Bcrp/abcg2 inhibitor
10/12/2006	CA2602372A1 Pyrimidine derivatives for use as anticancer agents
10/12/2006	CA2601649A1 Process for the preparation of anastrozole
10/11/2006	EP1710307A2 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA)
10/11/2006	EP1710304A1 Process for producing polymer composite of protein
10/11/2006	EP1710256A1 Human monoclonal antibodies to prostate specific membrane antigen
10/11/2006	EP1710254A2 Inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
10/11/2006	EP1710242A1 Substituted 2-(2,6-Dioxo-3-Fluoropiperidine-3-YL)-Isoindolines and their use to reduce TNF-alpha levels
10/11/2006	EP1710236A1 Derivatives of pyridine and quinoline
10/11/2006	EP1709976A1 Emt- inducing agents
10/11/2006	EP1709973A1 Method of suppressing cancer
10/11/2006	EP1709972A1 Use of an antibody against the laminin receptor or laminin receptor precursor for the treatment or diagnosis of several cancer types
10/11/2006	EP1709968A1 P2x receptor inhibitor
10/11/2006	EP1709965A2 Methods of treating cytokine mediate diseases
10/11/2006	EP1709175A2 Hif oligonucleotide decoy molecules
10/11/2006	EP1709083A1 Adenocarcinoma specific antibody sam-6, and uses thereof
10/11/2006	EP1709063A2 Glycosylated steroid derivatives with anti-migratory activity
10/11/2006	EP1709051A1 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
10/11/2006	EP1709007A1 N-4-(6-(heteo)aryl-pyrimidin-4-ylaminophenyl)-benzenesulfonamides as kinase inhibitors
10/11/2006	EP1709000A1 Piperidine derivatives as gcs inhibitors
10/11/2006	EP1708994A1 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics
10/11/2006	EP1708753A1 Use of goat serum for veterinary treatment
10/11/2006	EP1708752A2 Polymer-bound antibody cancer therapeutic agent
10/11/2006	EP1708724A1 Composition comprising xanthoceras sorbifolia extracts, compounds isolated from same, methods for preparing same and uses thereof
10/11/2006	EP1708712A1 Treatment of malignant gliomas with tgf-beta inhibitors
10/11/2006	EP1708695A1 Compositions and method for treatment of steroid/nuclear receptor-mediated diseases
10/11/2006	EP1708693A1 Pharmaceutical compositions containing paltinum complexes with secondary xanthates and therapeutic uses thereof
10/11/2006	EP1399150A4 Vitamin c compositions
10/11/2006	EP1363903B1 Indole derivatives and their use as gnrh antagonists
10/11/2006	EP1306375B1 Salts of benzimidazole compound and application thereof
10/11/2006	EP1216232B1 Heterocyclic compounds and methods for modulating cxcr3 function
10/11/2006	EP1210374B1 Human monoclonal antibodies to prostate specific membrane antigen
10/11/2006	EP1183250B1 Semi-synthesis of paclitaxel using dialkyldichlorosilanes
10/11/2006	EP1181013B1 Method and composition for the treatment of cancer
10/11/2006	EP1175436B1 Transiently immortalized cells for use in gene therapy
10/11/2006	EP1173476B1 Soybean protein nutraceuticals
10/11/2006	EP1140149B1 Use of human growth hormone to increase the number of circulating cd34+ cells, intended for reconstitution of the hematopoietic and immune systems following myeloablative or antiblastic therapies, by transplantation, re-infusion or engraftment
10/11/2006	EP1133311B1 INFLUENCING ANGIOGENESIS USING CD66a
10/11/2006	EP1070118B1 Modified adenovirus containing a fiber replacement protein
10/11/2006	EP1049465B1 Use of inhibitors for the treatment of disorders related to rtk hyperfunction, especially cancer
10/11/2006	EP0983070B1 Prevention of ovarian cancer by administration of a vitamin d compound
10/11/2006	EP0972041B1 Novel human delta3 compositions and therapeutic and diagnostic uses therefor
10/11/2006	EP0944619B1 Novel integrin receptor antagonists
10/11/2006	EP0914448B1 Lipid kinase
10/11/2006	EP0896586B1 ErbB3 ANTIBODIES
10/11/2006	EP0668777B1 Prostate-specific membrane antigen
10/11/2006	CN1845925A Substituted heterocycles
10/11/2006	CN1845755A Anti-CD20 therapy of ocular disorders
10/11/2006	CN1845746A Anti-tumor formulations comprising defibrotide alone or in combination with other anti-tumor agents
10/11/2006	CN1845741A TRP-P8 active compounds and therapeutic treatment methods
10/11/2006	CN1845734A Benzimidazole derivatives and their use as protein kinases inhibitors
10/11/2006	CN1844386A siRNA target gene sequence inhibiting gene expression of vascular endothelial growth factor
10/11/2006	CN1844376A Recombinant herpes simplex virus type 2 and its preparing method and use
10/11/2006	CN1844372A Amplification in vitro method for T lymphocyte specific for tumour antigen
10/11/2006	CN1844160A Sulfonated changium root polysaccharides and preparing method and use thereof
10/11/2006	CN1844151A Monoclonal antibody against human CD40 mutant molecule and its use
10/11/2006	CN1844146A Monoclonal antibody against human B7-1 molecule and its use
10/11/2006	CN1844127A Caffeoyl guinic acid-1-phosphate and its preparation and use
10/11/2006	CN1844122A Benzoporphyrin chlorophyll photosensitizer and its preparation process and use
10/11/2006	CN1844118A Piperidine-2,6-dione derivatives capable of inhibiting cell from releasing tumor necrosis factor
10/11/2006	CN1844084A Beta-elemene amino acid or carboxylic acid derivatives and preparation process and use thereof
10/11/2006	CN1843511A Use of ShRNA for suppressing telomere enzyme reverse transcriptase hTERT expression in antineoplastic action
10/11/2006	CN1843492A Traditional Chinese medicine preparation for treating mammary gland hyperplasia
10/11/2006	CN1843484A Medicine for treating mammary gland tumor
10/11/2006	CN1843479A Medicine for regulating incretion, promoting immunity, promoting tumor cell apoptosis and its preparation method
10/11/2006	CN1843401A Emulsifier containing rabdosia general terpene for with antineoplastic function
10/11/2006	CN1843384A Tetraselmis chui polysaccharide protein possessing antineoplastic function
10/11/2006	CN1843378A Traditional Chinese medicine for treating cancer and tumor and all kinds of inflammatory disease
10/11/2006	CN1843355A Pharmaceutical composition containing oxidized sophoridine or its salt, its preparation method and uses
10/11/2006	CN1843346A Pharmaceutical composition containing paclitaxel analog compound and its preparation method
10/11/2006	CN1843332A Slow release injection containing blood vessel inhibitor and cell toxicant medicine
10/11/2006	CN1279168C Method for obtaining modified immunoglobulins with reduced immunogenicity of murine antibody variable domains and compositions containing them
10/11/2006	CN1279058C Engineering antibody against CD44 for inducing leukemia cell differentiation and necrosis, its carrier and use
10/11/2006	CN1279056C Specific antibody of tumor-associated antigen SM5-1 and use thereof
10/11/2006	CN1279044C Non-steroidal progesterone receptor modulators
10/11/2006	CN1279042C 3-aryl-Beta-carboline-1-ketone compound, and its preparing method and use
10/11/2006	CN1279034C Dna－pk抑制剂 Dna-pk inhibitors
10/11/2006	CN1279030C Complex of 3,6-bi(2'-hydroxy-5'-chlorphenyl)-S-tetrazine and transition metal, its preparation and application
10/11/2006	CN1279029C Pyrazolobenzodiazepines as CDK2 inhibitors
10/11/2006	CN1279026C Prostaglandin endoperoxide H synthase biosynthesis inhibitors
10/11/2006	CN1279014C Vitamin A analogue derivative with antiangiogenic, antitumoral and proapoptotic activities
10/11/2006	CN1278739C Medicine box containing anti human spermatine single chain antibody/human carboxypeptidase A fusion protein and precursor medicine
10/11/2006	CN1278732C Compound formulation of traditional Chinese medicine for assistant treatment of tumour and preparation method thereof

1 ... 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 ... 2211